Daniel Drucker [Biomarker April 2023] To date, the adverse event profile of GLP-1R agonists is characterized by relatively mild gastrointestinal (GI) side effects, such as nausea, vomiting, and diarrhea
Why this matters more than it appears It affects high-value consumers: GLP-1 users tend to skew higher income and more health-consciousgroups that disproportionately drive premium alcohol sales
But GLP-1 meds often reduce appetite and thirst , which means many patients end up dehydrated
11 The reduced craving and the relapsed drinking in the alcohol withdrawal mice might be from the neurobiological impacts of liraglutide related to replenishing the dendritic spine density in the medial prefrontal cortex and the hippocampus as well as from enhancing the synaptic proteins
Sipping fluids between meals can help save stomach space for food, and some people use electrolyte options for added support on active days or when intake is lower
People taking GLP-1 with insulin or sulfonylurea drugs need to watch for low blood sugar more carefully